Cannabis Capital

Caitlyn Krebs | Nalu Bio

Episode Summary

Learning from nature, delivering through chemistry. The end of cannabis prohibition has made cannabis research possible which has generated a wave of cannabis biotech start-ups. Caitlyn Krebs the co-founder and CEO of Nalu Bio joins Ross O'Brien and Maggie Kelly from Bonaventure Equity to talk about the challenges and opportunities of being at the intersection of biotech and cannabis. As an entrepreneur with many successful exits under her belt she also shares advice for aspiring entrepreneurs. Produced by PodConX Cannabis Capital - https://podconx.com/podcasts/cannabis-capital Ross O'Brien - https://podconx.com/guests/ross-obrien Maggie Kelly - https://podconx.com/guests/maggie-kelly Bonaventure Equity - https://www.bvequity.com/ Caitlyn Krebs - https://podconx.com/guests/caitlyn-krebs Nalu Bio - https://www.nalubio.com/

Episode Notes

Learning from nature, delivering through chemistry.

   The end of cannabis prohibition has made cannabis research possible which has generated a wave of cannabis biotech start-ups.  Caitlyn Krebs the co-founder and CEO of Nalu Bio joins Ross O'Brien and Maggie Kelly from Bonaventure Equity to talk about the challenges and opportunities of being at the intersection of biotech and cannabis.   As an entrepreneur with many successful exits under her belt she also shares advice for aspiring entrepreneurs.

Produced by PodConX

 

Cannabis Capital - https://podconx.com/podcasts/cannabis-capital

Ross O'Brien -  https://podconx.com/guests/ross-obrien

Maggie Kelly - https://podconx.com/guests/maggie-kelly

Bonaventure Equity - https://www.bvequity.com/

Caitlyn Krebs - https://podconx.com/guests/caitlyn-krebs

Nalu Bio - https://www.nalubio.com/